Skip to main content
SpringerLink
Log in

Matrix metalloproteinase-3 (MMP-3) -1612 5A/6A promoter polymorphism in coronary artery disease in Indian population

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Matrix metalloproteinases (MMPs) play important role in the pathogenesis of coronary artery disease (CAD). 5A allele of -1612 5A/6A polymorphism of MMP-3 is associated with two fold higher activity than 6A allele. Present study was designed to analyse the association of this polymorphism with CAD in Indian population. Subjects included in the study were patients with stable angina (n=35), unstable angina (n=53), patients with recent event of myocardial infarction (MI) (MI Group-1, n=56) and patients at presentation of the acute MI (MI Group-2, n=49). Controls were healthy individuals (n=99). Genotyping of MMP-3 5A/6A polymorphism was carried out by PCR-based restriction digestion method. The genotype distribution of patient groups did not deviate from controls. Serum MMP-3 levels were significantly elevated at presentation of the acute MI by 36.8% (P=0.031) as compared to controls and more associated with 6A genotype suggesting discrepancy between in vitro transfection experiment and peripheral MMP-3 levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mtairag EM, Chollet-Martin S, Oudghiri M, Laquay N, Marie-Paule J, Jean-Baptiste, et al. Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion. Cardiovasc Res 2001; 49: 882–890.

    Article  Google Scholar 

  2. Ardans JA, Blum A, Mangan PR, Wientroub S, Cannon RO 3rd, Wahl LM. Raloxifene-mediated increase in matrix metalloproteinase-1 production by activated monocytes. Arterioscler Thromb Vasc Biol 2001; 21: 1265–1268.

    Article  CAS  PubMed  Google Scholar 

  3. Ravn HB, Falk E. Histopathology of plaque rupture. Cardiol Clin 1999; 17: 263–270.

    Article  CAS  PubMed  Google Scholar 

  4. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995; 92: 1565–1569.

    CAS  PubMed  Google Scholar 

  5. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94: 2493–2503.

    Article  CAS  PubMed  Google Scholar 

  6. Woessner JJ. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5: 2145–2154.

    CAS  PubMed  Google Scholar 

  7. Henney A, Wakeley P, Davies M, Foster K, Hembry R, Murphy G, et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci USA 1991; 88: 8154–8158.

    Article  CAS  PubMed  Google Scholar 

  8. Ye S, Watts G, Mandalia S, Humphries S, Henney A. Preliminary report: Genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J 1995; 73: 209–215.

    Article  CAS  PubMed  Google Scholar 

  9. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 1996; 271: 13055–13060.

    Article  CAS  PubMed  Google Scholar 

  10. Ghilardi G, Biondi ML, DeMonti M, Turri O, Guagnellini E, Scorza R. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke 2002; 33: 2408–2412.

    Article  CAS  PubMed  Google Scholar 

  11. Medley TL, Kingwell BA, Gatzka CD, Pillay P, Cole TJ. Matrixmetalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ Res 2003; 92: 1254–1261.

    Article  CAS  PubMed  Google Scholar 

  12. Enas A Enas, Senthilkumar A. Coronary Artery Disease In Asian Indians: An Update And Review. Int J Cardiol 2002; 1(2). Avalable via http://www.ispub.com/journal/the_internet_journal_of_cardiology/volume_1_number_2_10/article/coronary_artery_disease_in_asian_indians_an_update_and_review.html

  13. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.

    Article  CAS  PubMed  Google Scholar 

  14. Terashima M, Akita H, Kanazawa K, Inoue N, Yamada S, Ito K, et al. Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction. Circulation 1999; 99: 2717–2719.

    CAS  PubMed  Google Scholar 

  15. Nojiri T, Morita H, Imai Y, Maemura K, Ohno M, Ogasawara K, et al. Genetic variations of matrix metalloproteinase-1 and -3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese. Int J Cardiol 2003; 92: 181–186.

    Article  PubMed  Google Scholar 

  16. Liu PY, Chen JH, Li YH, Wu HL, Shi GY. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction. Thromb Haemost 2003; 90:132–139.

    CAS  PubMed  Google Scholar 

  17. Zhou X, Huang J, Chen J, Su S, Chen R, Gu D. Haplotype analysis of the matrix metalloproteinase-3 gene and myocardial infarction in a Chinese Han population. The Beijing Atherosclerosis Study. Thromb Haemost 2004; 92: 867–873.

    CAS  PubMed  Google Scholar 

  18. Beyzade S, Zhang S, Wong YK, Day IN, Eriksson P, Ye S. Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J Am Coll Cardiol 2003; 41: 2130–2137.

    Article  CAS  PubMed  Google Scholar 

  19. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002; 347: 1916–1923.

    Article  CAS  PubMed  Google Scholar 

  20. Kim JS, Park HY, Kwon JH, Im EK, Choi D, Jang Y et al. The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina. Yonsei Med J 2002; 43: 473–481.

    CAS  PubMed  Google Scholar 

  21. Pollanen PJ, Lehtimaki T, Ilveskoski E, Mikkelsson J, Kajander OA, Laippala P, et al. Coronary artery calcification is related to functional polymorphism of matrix metalloproteinase 3: the Helsinki Sudden Death Study. Atherosclerosis 2002; 164: 329–335.

    Article  CAS  PubMed  Google Scholar 

  22. Gao B, Li ZC. Association between serum matrix metalloproteinase-3 concentration and the promoter 5A/6A polymorphism in patients with coronary heart disease. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2004; 16: 536–539.

    CAS  PubMed  Google Scholar 

  23. Samnegard A, Silveira A, Lundman P, Boquist S, Odeberg J, Hulthe J et al. Serum matrix metalloproteinase-3 concentration is influenced by MMP-3-1612 5A/6A promoter genotype and associated with myocardial infarction. J Int Med 2005; 258: 411–419.

    Article  CAS  Google Scholar 

  24. Braganza DM, Benett MR. New insights into atherosclerotic plaque rupture. Postgrad Med J 2001; 77: 94–98.

    Article  CAS  PubMed  Google Scholar 

  25. Noji Y, Kajinami K, Kawashiri M, Todo Y, Horita T, Nohara A, et al. Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis. Clin Chem Lab Med 2001; 39: 380–384.

    Article  CAS  PubMed  Google Scholar 

  26. Beaudeux JL, Giral P, Bruckert E, Bernard M, Foglietti MJ, Chapman MJ. Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia. Atherosclerosis 2003; 169: 139–146.

    Article  CAS  PubMed  Google Scholar 

  27. White AJ, Duffy SJ, Walton AS, Ng JF, Rice GE, Mukherjee S, et al. Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary disease. Cardiovasc Res 2007; 75: 813–820.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sir H. N. Medical Research Society, Sir H. N. Hospital and Research Centre, Raja Rammohan Roy Road, Mumbai, 400 004, India

    Kavita K. Shalia, R. Mokal, S. S. Mithbawkar, M. Bootwalla, P. Sadvekar & P. K. Thakur

  2. Department of Cardiology, Sir H. N. Hospital and Research Centre, Raja Rammohan Roy Road, Mumbai, 400 004, India

    V. K. Shah, M. R. Mashru, S. L. Soneji & J. B. Vasvani

  3. Department of Cardiology, Rajawadi Municipal Hospital, Ghatkopar (East), Mumbai, India

    S. Payannavar & A. Walvalkar

Authors
  1. Kavita K. Shalia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. K. Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. R. Mashru
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. L. Soneji
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. B. Vasvani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Payannavar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Walvalkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. Mokal
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S. S. Mithbawkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M. Bootwalla
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. P. Sadvekar
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. P. K. Thakur
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kavita K. Shalia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shalia, K.K., Shah, V.K., Mashru, M.R. et al. Matrix metalloproteinase-3 (MMP-3) -1612 5A/6A promoter polymorphism in coronary artery disease in Indian population. Indian J Clin Biochem 25, 133–140 (2010). https://doi.org/10.1007/s12291-010-0025-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-010-0025-y

Key Words

Search

Navigation